Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=112 Randomized Double-blind Prevention

Red-Rubber Catheter to Facilitate Nasotracheal Intubation in Adult Patients

Intubation;Difficult

Bottom Line

View on ClinicalTrials.gov: NCT03779984 ↗
Enrolled (actual)
112
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: The Number of Participants With Nasal Bleeding — 22; 35 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Red Rubber Catheter (Device); Standard nasal tracheal Intubation (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Texas Southwestern Medical Center
Primary completion
Dec 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
The Number of Participants With Nasal Bleeding		 22; 35 —
SECONDARY
The Number of Participants With Severe Epistaxis		 1; 1 —

Summary

This study was designed to compare the effectiveness of using a red-rubber catheter versus standard, direct insertion of a thermosoftened, lubricated nasal endotracheal tube into the naris to facilitate nasotracheal intubation in adults. This study will assess if the red-rubber catheter method leads to lower incidence and severity of epistaxis, faster time to intubation, and higher patient satisfaction compared to the current standard of care.

Eligibility Criteria

Inclusion Criteria

  • Age > 18, male and female
  • Subjects undergoing surgery requiring NTI
  • ASA 1-3

Exclusion Criteria

  • History of anticoagulant use or coagulopathy
  • History of latex allergy
  • History of difficult airway
  • Anticipated difficult airway requiring awake intubation
  • Abnormal anatomy of the nasal passage (due to prior trauma, surgery, congenital defects, etc.) or basilar skull fracture
  • Patients unable to be placed in the sniffing position
  • Morbid obesity with BMI > 40
  • Pregnancy
  • ASA 4
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03779984). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search